Search results
Oakley founder James Jannard sells Malibu mansion for $210 million — a California record
Los Angeles Times· 3 days agoIn a historic deal, Oakley founder James Jannard has sold his Malibu mansion for $210 million. The ...
Oakley founder sells Malibu mansion for a breathtaking $210M — setting a new record for California
NY Post via Yahoo Finance· 3 days agoGoogle Maps Malibu, a celebrity and billionaire playground just 45 minutes from LA, now claims the...
Nvidia Is Surging. Why That’s a Problem for a Tech ETF.
Barrons.com· 4 hours agoThe IRS has rules about concentration levels in funds. As the Tech Select Sector SPDR rebalances,...
An In-Depth Timeline of Brad Pitt and Angelina Jolie’s Divorce Drama
The Daily Beast via Yahoo News· 2 hours agoIn the eight years since Angelina Jolie filed for divorce from Brad Pitt due to his alleged physical...
Inside Out 2 overtakes Dune: Part Two with biggest box office debut of 2024
The Independent via Yahoo News· 5 days agoDiscluding the month when cinemas were closed during the pandemic, May’s US ticket sales were the...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 16 hours agoThe FDA is expected to give its decision later this year. Donanemab will be the second drug on the...
Eli Lilly’s Weight-Loss Franchise Has Been a Massive Winner Under Dave Ricks
Barrons.com· 12 hours agoIt recently bought a factory in Wisconsin that could be on-line by next year. In the meantime, Lilly...
Is Eli Lilly Stock A Buy After FDA Advisors Back Its Alzheimer's Drug?
Investor's Business Daily· 1 day agoIn 2029, analysts expect the two drugs to bring in $29.95 billion and $20.33 billion in sales,...
WHO warns of “harmful” fake Ozempic in circulation in Americas and Europe
Pharmaceutical Technology via Yahoo Finance· 14 hours agoThe World Health Organization (WHO) has issued an alert on falsified versions of Novo Nordisk’s ...
Forget Eli Lilly, Buy This Magnificent Biotech Stock Instead
Motley Fool via Yahoo Finance· 18 hours agoMeanwhile, the commercial launch of Casgevy, as a one-time functional cure for sickle cell disease...